From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

Introduction: Given the characteristics of meningococcal carriage and transmission and the sudden, often severe onset and long-term consequences of disease, vaccination can most effectively provide large-scale control of invasive disease. Six serogroups (A, B, C, W, X, and Y) cause nearly all mening...

Full description

Bibliographic Details
Main Authors: John L. Perez, Judith Absalon, Johannes Beeslaar, Paul Balmer, Kathrin U. Jansen, Thomas R. Jones, Shannon Harris, Laura J. York, Qin Jiang, David Radley, Annaliesa S. Anderson, Graham Crowther, Joseph J. Eiden
Format: Article
Language:English
Published: Taylor & Francis Group 2018-06-01
Series:Expert Review of Vaccines
Subjects:
bivalent rlp2086
factor h binding protein
menb-fhbp
meningococcal serogroup b disease
trumenba®
vaccine coverage
Online Access:http://dx.doi.org/10.1080/14760584.2018.1483726

Internet

http://dx.doi.org/10.1080/14760584.2018.1483726

Similar Items